These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Environmental factors and host responses in asthma. Feinberg S Acta Allergol; 1974; 29 Suppl 11(0):7-14. PubMed ID: 4215275 [No Abstract] [Full Text] [Related]
27. [Clinico-immunologic aspects of using mildronate in patients with bronchopulmonary diseases]. Orlov VA; Sokolova VI; Zamotaev IP; Elagina LV; Zavolovskaia LI Antibiot Khimioter; 1990 Jul; 35(7):47-50. PubMed ID: 2149494 [TBL] [Abstract][Full Text] [Related]
28. The effect of drug premedication on skin test results with Aspergillus antigen. Grigg CF Ann Allergy; 1976 Nov; 37(5):380. PubMed ID: 826197 [No Abstract] [Full Text] [Related]
29. Immunological mechanisms in asthma. Pepys J Ciba Found Study Group; 1971; 38():86-98. PubMed ID: 5005206 [No Abstract] [Full Text] [Related]
30. Asthma due to inhaled chemical agents--complex salts of platinum. Pepys J; Pickering CA; Hughes EG Clin Allergy; 1972 Dec; 2(4):391-6. PubMed ID: 4629302 [No Abstract] [Full Text] [Related]
31. Hypersensitivity pneumonitis concomitant with acute airway obstruction after exposure to hay dust. Baur X; Dexheimer E Respiration; 1984; 46(4):354-61. PubMed ID: 6522842 [TBL] [Abstract][Full Text] [Related]
32. Effect of cromolyn sodium and of daily exposure to compound 48/80 on experimental asthma. Ambrus LC; Thurber L Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):491-4. PubMed ID: 239445 [TBL] [Abstract][Full Text] [Related]
33. Effector pathways of allergic reactions and their possible therapeutic modifications. Pepys J Trans Ophthalmol Soc U K (1962); 1971; 91():463-6. PubMed ID: 5004366 [No Abstract] [Full Text] [Related]
34. Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. Hoag JE; McFadden ER Ann Allergy; 1991 Jan; 66(1):53-63. PubMed ID: 1702945 [TBL] [Abstract][Full Text] [Related]
35. Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Brogden RN; Speight TM; Avery GS Drugs; 1974; 7(3):164-282. PubMed ID: 4212341 [No Abstract] [Full Text] [Related]
36. Asthma--site of airway obstruction and aerosol deposition. Mossberg B Eur J Respir Dis Suppl; 1984; 136():49-53. PubMed ID: 6428931 [No Abstract] [Full Text] [Related]
37. Protection from exercise-induced asthma by pre-exercise cromolyn sodium and its relationship to serum IGE levels. Morton AR; Turner KJ; Fitch KD Ann Allergy; 1973 Jun; 31(6):265-71. PubMed ID: 4197023 [No Abstract] [Full Text] [Related]
38. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma. Amayasu H; Nakabayashi M; Akahori K; Ishizaki Y; Shoji T; Nakagawa H; Hasegawa H; Yoshida S Ann Allergy Asthma Immunol; 2001 Aug; 87(2):146-50. PubMed ID: 11527248 [TBL] [Abstract][Full Text] [Related]
39. Autoimmune antibodies in intrinsic (non-atopic) asthma. Lidor Y; Topilsky M; Spitzer SA; Yehoshua H Ann Allergy; 1980 May; 44(5):296-8. PubMed ID: 7377641 [TBL] [Abstract][Full Text] [Related]